                         SEQUENCE LISTING

<110>  Novo Nordisk A/S
 
<120>  PEPTIDE COMPOUNDS AND USE

<130>  8504.000-EP

<160>  3     

<170>  PatentIn version 3.5

<210>  1
<211>  36
<212>  PRT
<213>  Homo sapiens

<400>  1

Ala Pro Leu Glu Pro Val Tyr Pro Gly Asp Asn Ala Thr Pro Glu Gln 
1               5                   10                  15      


Met Ala Gln Tyr Ala Ala Asp Leu Arg Arg Tyr Ile Asn Met Leu Thr 
            20                  25                  30          


Arg Pro Arg Gln 
        35      


<210>  2
<211>  36
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Analogue of PP


<220>
<221>  MISC_FEATURE
<222>  (32)..(32)
<223>  This position is Aib

<400>  2

Ala Pro Leu Glu Pro Val Tyr Pro Gly Asp Asn Ala Thr Pro Glu Gln 
1               5                   10                  15      


Leu Ala Arg Tyr Tyr Lys Ala Leu Arg His Tyr Ile Asn Leu Ala Gly 
            20                  25                  30          


Arg Gln Arg Gln 
        35      


<210>  3
<211>  36
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Analogue of PP


<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  This position contains an acylation group

<220>
<221>  MISC_FEATURE
<222>  (32)..(32)
<223>  This position is Aib

<400>  3

Ala Pro Leu Glu Pro Val Tyr Pro Gly Asp Asn Ala Thr Pro Glu Gln 
1               5                   10                  15      


Leu Ala Arg Tyr Tyr Lys Ala Leu Arg His Tyr Ile Asn Leu Ala Gly 
            20                  25                  30          


Arg Gln Arg Gln 
        35      


